Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1967 1
1968 1
1969 1
1970 1
1971 1
1972 1
1973 1
1974 1
1975 3
1978 2
1979 2
1980 1
1982 1
1983 2
1985 2
1986 3
1987 2
1990 2
1992 7
1993 6
1994 13
1995 20
1996 27
1997 31
1998 50
1999 62
2000 78
2001 98
2002 88
2003 107
2004 112
2005 159
2006 148
2007 174
2008 168
2009 181
2010 221
2011 230
2012 281
2013 293
2014 317
2015 343
2016 386
2017 412
2018 435
2019 514
2020 610
2021 690
2022 700
2023 699
2024 277

Text availability

Article attribute

Article type

Publication date

Search Results

6,874 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for flair
Search for flamir instead (1 results)
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study.
Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, Kim JS, Breuer L, Singer OC, Warach S, Christensen S, Treszl A, Forkert ND, Galinovic I, Rosenkranz M, Engelhorn T, Köhrmann M, Endres M, Kang DW, Dousset V, Sorensen AG, Liebeskind DS, Fiebach JB, Fiehler J, Gerloff C; STIR and VISTA Imaging Investigators. Thomalla G, et al. Lancet Neurol. 2011 Nov;10(11):978-86. doi: 10.1016/S1474-4422(11)70192-2. Epub 2011 Oct 4. Lancet Neurol. 2011. PMID: 21978972 Clinical Trial.
METHODS: In this multicentre observational study, we analysed clinical and MRI data from patients presenting between Jan 1, 2001, and May 31, 2009, with acute stroke for whom DWI and FLAIR were done within 12 h of observed symptom onset. Two neurologists masked to clinical …
METHODS: In this multicentre observational study, we analysed clinical and MRI data from patients presenting between Jan 1, 2001, and May 31 …
Acute glomerulonephritis.
Sethi S, De Vriese AS, Fervenza FC. Sethi S, et al. Lancet. 2022 Apr 23;399(10335):1646-1663. doi: 10.1016/S0140-6736(22)00461-5. Lancet. 2022. PMID: 35461559 Review.
All glomerulonephritis disorders can show periods of exacerbation, but disease flairs characteristically occur in patients with IgA nephropathy or C3 glomerulopathy. ...
All glomerulonephritis disorders can show periods of exacerbation, but disease flairs characteristically occur in patients with IgA n …
FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols.
Zrzavy T, Wielandner A, Haider L, Bartsch S, Leutmezer F, Berger T, Nenning KH, Rauscher A, Rommer P, Kasprian G. Zrzavy T, et al. J Neurol. 2022 Jan;269(1):461-467. doi: 10.1007/s00415-021-10833-x. Epub 2021 Oct 8. J Neurol. 2022. PMID: 34623512 Free PMC article.
OBJECTIVE: To compare lesion detection of 3D-FLAIR(2) with state-of-the-art 3D-T2-FLAIR and 3D-T2-weighted images. ...Comparing LC lesion detection in 3D-FLAIR(2) vs. 3D-FLAIR, 3D-FLAIR(2) detected on average 3.2 more cortical lesions (95% CI - …
OBJECTIVE: To compare lesion detection of 3D-FLAIR(2) with state-of-the-art 3D-T2-FLAIR and 3D-T2-weighted images. ...Comparin …
T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination.
Li M, Huang W, Chen H, Jiang H, Yang C, Shen S, Cui Y, Dong G, Ren X, Lin S. Li M, et al. Front Neurol. 2022 Feb 2;13:819216. doi: 10.3389/fneur.2022.819216. eCollection 2022. Front Neurol. 2022. PMID: 35185770 Free PMC article.
METHODS: A consecutive cohort of 246 GBM patients with regular follow-up and sufficient radiological data was included in this study. The series of T2/FLAIR and T1CE images were retrospectively reviewed. The patients were separated into T2/FLAIR and T1CE discordant …
METHODS: A consecutive cohort of 246 GBM patients with regular follow-up and sufficient radiological data was included in this study. The se …
The Technical and Clinical Features of 3D-FLAIR in Neuroimaging.
Naganawa S. Naganawa S. Magn Reson Med Sci. 2015;14(2):93-106. doi: 10.2463/mrms.2014-0132. Epub 2015 Mar 31. Magn Reson Med Sci. 2015. PMID: 25833275 Free article. Review.
There are more than 100 reports regarding 3D-FLAIR in the PubMed database. In this article, the technical and clinical features of 3D-FLAIR for neuroimaging are reviewed and summarized. 3D-FLAIR allows thinner slices with multi-planar reformation capability, …
There are more than 100 reports regarding 3D-FLAIR in the PubMed database. In this article, the technical and clinical features of 3D …
T1w/FLAIR ratio standardization as a myelin marker in MS patients.
Cappelle S, Pareto D, Sunaert S, Smets I, Laenen A, Dubois B, Demaerel P. Cappelle S, et al. Neuroimage Clin. 2022;36:103248. doi: 10.1016/j.nicl.2022.103248. Epub 2022 Oct 25. Neuroimage Clin. 2022. PMID: 36451354 Free PMC article.
The nonlinear methods of calibration showed the best results for calculating the T1w/FLAIR ratio with a smaller dispersion of the data and a smaller overlap of T1w/FLAIR ratio in the different segmented brain structures. T1w/T2w and T1w/FLAIR ratios showed a …
The nonlinear methods of calibration showed the best results for calculating the T1w/FLAIR ratio with a smaller dispersion of the dat …
T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor.
Onishi S, Amatya VJ, Kolakshyapati M, Takano M, Yonezawa U, Taguchi A, Kaichi Y, Takeshima Y, Awai K, Sugiyama K, Kurisu K, Yamasaki F. Onishi S, et al. Eur J Radiol. 2020 May;126:108924. doi: 10.1016/j.ejrad.2020.108924. Epub 2020 Mar 2. Eur J Radiol. 2020. PMID: 32193035
PURPOSE: T2-FLAIR mismatch sign was reported as specific imaging marker in non-enhancing diffuse astrocytoma, IDH-mutant & 1p/19q non-codeleted. However, most of the previous studies for T2-FLAIR mismatch sign were confirmed only among lower grade glioma. ...
PURPOSE: T2-FLAIR mismatch sign was reported as specific imaging marker in non-enhancing diffuse astrocytoma, IDH-mutant & 1p/19q …
An Automatic DWI/FLAIR Mismatch Assessment of Stroke Patients.
Johansen J, Offersen CM, Carlsen JF, Ingala S, Hansen AE, Nielsen MB, Darkner S, Pai A. Johansen J, et al. Diagnostics (Basel). 2023 Dec 27;14(1):69. doi: 10.3390/diagnostics14010069. Diagnostics (Basel). 2023. PMID: 38201378 Free PMC article.
DWI/FLAIR mismatch assessment for ischemic stroke patients shows promising results in determining if patients are eligible for recombinant tissue-type plasminogen activator (r-tPA) treatment. ...In this article, we present a simple automatic method for segmenting stroke-re …
DWI/FLAIR mismatch assessment for ischemic stroke patients shows promising results in determining if patients are eligible for recomb …
Radiomic signature of DWI-FLAIR mismatch in large vessel occlusion stroke.
Regenhardt RW, Bretzner M, Zanon Zotin MC, Bonkhoff AK, Etherton MR, Hong S, Das AS, Alotaibi NM, Vranic JE, Dmytriw AA, Stapleton CJ, Patel AB, Kuchcinski G, Rost NS, Leslie-Mazwi TM. Regenhardt RW, et al. J Neuroimaging. 2022 Jan;32(1):63-67. doi: 10.1111/jon.12928. Epub 2021 Sep 10. J Neuroimaging. 2022. PMID: 34506667 Free PMC article.
Radiomic features were extracted from within the lesions on DWI and FLAIR. The DWI-FLAIR mismatch radiomics signature was built with features systematically selected by a cross-validated ElasticNet linear regression model of mismatch. ...Inter-rater agreement for vi …
Radiomic features were extracted from within the lesions on DWI and FLAIR. The DWI-FLAIR mismatch radiomics signature was buil …
T2-FLAIR mismatch sign correlates with (11)C-methionine uptake in lower-grade diffuse gliomas.
Ebiko Y, Tamura K, Hara S, Inaji M, Tanaka Y, Nariai T, Ishii K, Maehara T. Ebiko Y, et al. J Neurooncol. 2023 Aug;164(1):257-265. doi: 10.1007/s11060-023-04417-0. Epub 2023 Aug 17. J Neurooncol. 2023. PMID: 37589920
PURPOSE: The T2-FLAIR mismatch sign is recognized as an imaging finding highly suggestive of IDH-mutant astrocytomas. ...The median T/N ratio of MET-PET in tumors with T2-FLAIR mismatch was 1.50, which was significantly lower than that of tumors without T2-FLAIR …
PURPOSE: The T2-FLAIR mismatch sign is recognized as an imaging finding highly suggestive of IDH-mutant astrocytomas. ...The median T …
6,874 results